No annual revenue total was found in PALOMINO LABORATORIES INC.'s SEC filings.
Palomino Laboratories Inc. (PALX) files with the SEC under industry code 3674, Semiconductors & Related Devices. As of Jun 30, 2026 it held $19.4 million in cash and investments and $167,882 in total debt.
Revenue
—
Net income (TTM)
$-5.18M
-878.7% vs year-ago TTM
Operating cash flow (TTM)
$-3.44M
-6135.1% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$-0.33
+85.4% vs year-ago TTM
Dividend per share
None
Shares outstanding
18.92M
+278.4% vs prior year
Net cash
$19.28M
as of Jun 30, 2026
Operating margin
—
Company profile
- Industry
- Semiconductors & Related Devices (SIC 3674)
- Listed as
- PALX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Goleta, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1938569
- Former names
- Unite Acquisition 3 Corp. (until Aug 29, 2025)
Other Semiconductors & Related Devices companies
- Nvidia Corp NVDA
- Broadcom Inc. AVGO
- Micron Technology Inc MU
- Advanced Micro Devices Inc AMD
- Intel Corp INTC
- Applied Materials Inc /DE AMAT
- Texas Instruments Inc TXN
- Arm Holdings PLC /UK ARM
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
|---|---|---|---|
| Operating income | -$2.7M | -$6,123 | — |
| Net income | -$3.2M | -$16,198 | -$83,937 |
| Diluted EPS | -$0.47 | -$0.01 | -$0.02 |
| Operating cash flow | -$1.3M | -$4,870 | -$79,379 |
| Total assets | $8.4M | $138,125 | $380 |
| Total liabilities | $336,458 | $156,431 | $111,621 |
| Stockholders' equity | $8.1M | -$18,306 | -$2,108 |
| Cash and investments | $8.1M | — | $380 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K/A | Amended current report | Oct 14, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
Aug 5, 2026 | Jul 31, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 16, 2026 | Jul 14, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Unregistered share sale
|
May 5, 2026 | Apr 30, 2026 |
All 52 Palomino Laboratories Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.